| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adverse drug reaction risks obtained from meta-analyses and pharmacovigilance disproportionality analyses are correlated in most cases
|
Khouri, Charles
|
|
|
134 |
C |
p. 14-21
|
artikel
|
| 2 |
Editorial Board
|
|
|
|
134 |
C |
p. IFC
|
artikel
|
| 3 |
Effect Modifiers and Statistical Tests for Interaction in Randomized Trials
|
Christensen, Robin
|
|
|
134 |
C |
p. 174-177
|
artikel
|
| 4 |
Framework for the treatment and reporting of missing data in observational studies: The Treatment And Reporting of Missing data in Observational Studies framework
|
Lee, Katherine J.
|
|
|
134 |
C |
p. 79-88
|
artikel
|
| 5 |
Hypothetical case replacement can be used to quantify the robustness of trial results
|
Frank, Kenneth A.
|
|
|
134 |
C |
p. 150-159
|
artikel
|
| 6 |
International application of PROMIS computerized adaptive tests: US versus country-specific item parameters can be consequential for individual patient scores
|
Terwee, Caroline B.
|
|
|
134 |
C |
p. 1-13
|
artikel
|
| 7 |
Let us not rush back to odds ratios without a recommendation to convert them to interpretable measures
|
Leucht, Stefan
|
|
|
134 |
C |
p. 172-173
|
artikel
|
| 8 |
Meta-epidemiological study of publication integrity, and quality of conduct and reporting of randomized trials included in a systematic review of low back pain
|
Hayden, J.A.
|
|
|
134 |
C |
p. 65-78
|
artikel
|
| 9 |
Methodological review showed that time-to-event outcomes are often inadequately handled in cluster randomized trials
|
Caille, Agnès
|
|
|
134 |
C |
p. 125-137
|
artikel
|
| 10 |
Patient reported outcome measures in clinical trials should be initially analyzed as continuous outcomes for statistical significance and responder analyses should be reserved as secondary analyses
|
Collister, David
|
|
|
134 |
C |
p. 95-102
|
artikel
|
| 11 |
PRISMA 2020
|
Tugwell, Peter
|
|
|
134 |
C |
p. A5-A6
|
artikel
|
| 12 |
Real-time imputation of missing predictor values improved the application of prediction models in daily practice
|
Nijman, Steven Willem Joost
|
|
|
134 |
C |
p. 22-34
|
artikel
|
| 13 |
Recommendation mapping of the World Health Organization's guidelines on tuberculosis: A new approach to digitizing and presenting recommendations
|
Hajizadeh, Anisa
|
|
|
134 |
C |
p. 138-149
|
artikel
|
| 14 |
Registered trials address questions already answered with high-certainty evidence: A sample of current redundant research
|
Vergara-Merino, Laura
|
|
|
134 |
C |
p. 89-94
|
artikel
|
| 15 |
Reply to: Let us not rush back to odds ratios in meta-analysis
|
Doi, Suhail A.
|
|
|
134 |
C |
p. 190
|
artikel
|
| 16 |
Table of Contents
|
|
|
|
134 |
C |
p. A2-A4
|
artikel
|
| 17 |
The MethodologicAl STandards for Epidemiological Research (MASTER) scale demonstrated a unified framework for bias assessment
|
Stone, Jennifer C.
|
|
|
134 |
C |
p. 52-64
|
artikel
|
| 18 |
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
|
Page, Matthew J.
|
|
|
134 |
C |
p. 178-189
|
artikel
|
| 19 |
Transparency, trust and minimizing burden to increase recruitment and retention in trials: a systematic review
|
Natale, Patrizia
|
|
|
134 |
C |
p. 35-51
|
artikel
|
| 20 |
Tutorial: A nontechnical explanation of the counterfactual definition of effect modification and interaction
|
Bours, Martijn J.L.
|
|
|
134 |
C |
p. 113-124
|
artikel
|
| 21 |
Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement
|
Page, Matthew J
|
|
|
134 |
C |
p. 103-112
|
artikel
|
| 22 |
Vancouver Coastal Health informed COVID-19 response by applying rapid review methodology: reply to Tricco
|
Dix-Cooper, Linda
|
|
|
134 |
C |
p. 167-171
|
artikel
|
| 23 |
Will COVID-19 result in a giant step backwards for women in academic science?
|
Shamseer, Larissa
|
|
|
134 |
C |
p. 160-166
|
artikel
|
Tijdschrift beschrijving